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Abstract
Background: Terminal dribbling is one of the lower urinary tract symptoms (LUTS) that has not been widely
studied. The aim of this study was to investigate the associations between terminal dribbling (TD) and other
parameters such as International Prostate Symptom Score (IPSS) and intravesical prostatic protrusion (IPP).
Methods: Medical records of male patients with LUTS aged 40 years and older were prospectively collected. Data
regarding TD defined by the International Continence Society standardization subcommittee, IPSS, prostate-specific
antigen, total prostate volume, and IPP on transrectal ultrasonography were obtained. TD was confirmed by the
subsequent uroflowmetry (uroflowmetry-confirmed TD). Logistic regression analysis was performed to identify the
parameters affecting TD and uroflowmetry-confirmed TD.
Results: Among the 578 men, 226 patients (39.1 %) complained of TD and 157 patients (27.2 %) had objective
findings of TD on uroflowmetry. In the logistic regression analysis, IPSS voiding subscore were correlated with TD
(Odds ratio 1.06). In addition, IPP was the only significant risk factor for uroflowmetry-confirmed TD (Odds ratio
2.83). Each question of IPSS is not correlated with TD or uroflowmetry-confirmed TD.
Conclusions: While the symptom of TD is well correlated with IPSS voiding subscore, objective evidence of TD on
uroflowmetry had strong correlation with IPP. TD should be investigated further to reveal its clinical impact and
guide a proper management.
Background
Terminal dribbling (TD) is known to be common in men
with or without benign prostate hyperplasia (BPH), and
has been shown to have a negative impact on quality of
life [1–3]. TD has been included in the symptom score
suggested by Boyarsky et al. and the International Contin-
ence Society (ICS) male questionnaire [4, 5]. In 1996, the
study done by Abrams et al. pointed out that objective evi-
dence of TD is significantly related with bladder outlet ob-
struction [6].
TD is newly defined by the ICS standardization subcom-
mittee in 2002 [7]. However, no study has been carried
out according to this definition up to now even though it
is the most common symptom among lower urinary tract
symptom (LUTS) in BPH patients or community people
[4]. In the present study, we sought to investigate the
prevalence of TD among LUTS patients and its
relationship with intravesical prostatic protrusion (IPP)
and with International Prostate Symptom Score (IPSS).
Methods
Study population
The study comprised 635 consecutive male LUTS patients
aged 40 years and older attending as new patients at the
outpatient clinic between January 2008 and July 2013. This
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study was conducted in accordance with the ethical stan-
dards laid down in the 1964 Declaration of Helsinki and its
later amendments; appropriate ethical review boards
(Korea University Medical Center Ansan Hospital IRB No.
AS 14156) approved this retrospective study. The patients
with LUTS mean that the patients who have storage symp-
toms, voiding symptoms or post micturition symptoms as
described in the previous study [7]. Fifty seven of these
men were excluded from our study due to biopsy proven
prostate cancer, other malignancies, previous medication
for LUTS, past history of surgery for BPH or other pelvic
diseases, neurologic abnormalities, or missing data. IPSS,
prostate-specific antigen (PSA), prostate volume, prostate
transitional zone volume and IPP on transrectal ultrason-
ography (TRUS), and the answer to the TD item on the
ICS male questionnaire were recorded for each subject.
Terminal dribbling definition and confirmation
TD was defined in the ICS guidelines as “when an individ-
ual describes a prolonged final part of micturition when
the flow has slowed to a trickle/dribble” [7]. The question-
naire item regarding TD was stated as follows: “Do you
have a prolonged final part of micturition when the flow
has slowed to a trickle/dribble?” Answer choices for this
question included yes and no. Uroflowmetry-confirmed
TD means that TD confirmed by the uroflowmetry when
the typical finding of slowly decreasing flow with trick-
ling/dribbling at the end of the void was observed.
Features measured using transrectal ultrasonography
The prostate was measured in three dimensions on TRUS,
and its volume and transitional volume were estimated
using a modification of the prolate ellipsoid formula and
expressed in cm3 (0.523 [length (cm) × width (cm) ×
height (cm)]) [8]. IPP was measured as the vertical dis-
tance from the tip of the protruding prostate to the base
of the urinary bladder in the sagittal plane, and it was
graded as mild (less than 5 mm), moderate (from 5 to less
than 10 mm), severe (10 mm or more) [9, 21]. Urology
residents performed this procedure under the supervision
of attendings. We divided patients into two groups based
on the presence of IPP when performing logistic regres-
sion analysis.
Acquisition of IPSS questionnaires
The severity of LUTS was measured using the IPSS, which
is based on the American Urological Association symp-
tom index with one additional question on quality of life
(QoL). After the patients were asked to complete the IPSS
questionnaire, voiding subscore (sum of scores in 1st, 3rd,
5th, and 6th question of IPSS) and storage subscore (sum
of scores in 2nd, 4th, and 7th question of IPSS) were
calculated [10]. The Korean version of the IPSS was also
validated in terms of relevance and reliability, and is now
used as a diagnostic tool for LUTS [11].
Statistical analysis
Continuous variables were expressed as either the mean ±
standard deviation, or median [inter-quartile range]. Cat-
egorical variables were reported as the number of occur-
rences and frequency. Student t-test and the Pearson χ2
test were used for statistical comparisons of continuous
and categorical variables, respectively. Simple and mul-
tiple logistic regressions with a backward variable selec-
tion procedure were performed to identify the
parameters affecting TD. Simple logistic regressions
were performed to reveal the association between TD
and IPSS. Data were analyzed using PASW Statistics
version 18.0 (SPSS, Inc. Chicago, IL, USA). We
regarded a p value <0.05 as statistically significant.
Results
Characteristics of enrolled patents
The mean age of subjects was 62.4 years, the median
prostate volume was 31.0 cm3, and the median transi-
tional volume was 12.0 cm3 (Table 1). Among 578 men
with LUTS, 226 men (39.1 %) complained of TD.
Among these 226 men who complained of TD, TD was
confirmed in 157 men (uroflowmetry-confirmed TD
group) by subsequent uroflowmetry. Typical findings
such as slowly decreasing flow with trickling/dribbling at
the end of the void were observed in these patients
(Fig. 1). When the patients were classified with age, 23
men (10.1 %) in their 40’s complained of TD, 65 men
(28.6 %) in their 50’s complained of TD, 81 men (35.7 %)
in their 60’s, and 58 men (25.6 %) in their 70’s, respect-
ively. There were no significant differences between TD
and non-TD groups with respect to age, PSA, prostate
volume or prostate transitional zone volume. However,
IPSS total score, IPSS voiding subscale score, IPSS storge
subscale score, and IPSS QoL score in TD group were
significantly higher than those in non-TD group. Among
578 men with LUTS, IPP was observed in 248 patients
(42.9 %). The number of patients with IPP was not sig-
nificantly different in TD group than that in non-TD
group (p value 0.402). When classified by uroflowmetry-
confirmed TD, the number of patients with IPP was sig-
nificantly higher in uroflowmetry-confirmed TD group
(95 out of 157) than that in patients who did not show
the typical finding of TD in uroflowmetry test (153 out
of 421) (Odds ratio 2.67).
The risk factors for terminal dribbling in the logistic
regression analysis
In the logistic regression analysis with a backward vari-
able selection procedure, voiding subscore was the only
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Fig. 1 Typical findings of terminal dribbling on uroflowmetry
Table 1 Baseline characteristics of enrolled patients
Variables All cases (n = 578) Terminal dribbling (n = 226) Non-Terminal dribbling (n = 352) p value
Age (years), mean ± SD 62.4 ± 10.8 62.2 ± 10.3 62.6 ± 11.03 0.775
PSA (ng/ml), median [IQR] 2.22 [0.75-5.46] 1.70 [0.73-4.81] 2.65 [0.76-5.87] 0.098
Prostate volume (cm3), median [IQR] 31.0 [23.0-44.0] 29.0 [22.0-43.0] 32.0 [23.0-45.0] 0.261
Prostate transitional zone volume (cm3), median [IQR] 12.0 [7.0-20.0] 10.0 [6.0-18.0] 13.0 [7.25-22.0] 0.116
IPSS total score, Mean ± SD 14.1 ± 8.67 15.7 ± 8.33 13.1 ± 8.72 <0.001
Voiding subscale score, mean ± SD 8.13 ± 5.76 9.23 ± 5.44 7.43 ± 5.85 <0.001
Storage subscale score, mean ± SD 5.99 ± 3.70 6.49 ± 3.67 5.66 ± 3.66 0.008
IPSS QoL score, Mean ± SD 3.64 ± 1.15 3.83 ± 1.07 3.51 ± 1.20 0.002
IPP (%) 248 (42.9 %) 100 (44.2 %) 148 (40.2 %) 0.402
Mild (%) 362 (15.3 %) 12 (12.0 %) 26 (17.6 %)
Moderate (%) 149 (60.1 %) 64 (64.0 %) 85 (57.4 %)
Severe (%) 65 (24.6 %) 24 (24.0 %) 37 (25.0 %)
IPSS = International Prostate Symptom Score; QoL = Quality of Life; IPP = intravesical prostatic protrusion
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significant risk factor for TD in the enrolled patients
(Odds ratio 1.06, Table 2). In addition, when the multiple
logistic regression analysis was performed to reveal the
significant factor for uroflowmetry-confirmed TD, IPP
was the only significant risk factor (Odds ratio 2.83,
Table 3). Each question of IPSS is not correlated with
TD or uroflowmetry-confirmed TD in the logistic re-
gression analysis.
Discussion
One of the difficulties encountered in earlier studies
regarding TD was the lack of a clear definition ensuring
that patients could discriminate it from post-void drib-
bling. The current concept of TD was first addressed on
the ICS male questionnaire and has been defined by ICS
recommendations in 2002 [4, 7]. Before this definition, the
studies performed in 1990s used various definitions of TD
[12–16]. Moreover, several reports have regarded TD as
an initial or mild form of post-void dribbling [13–15].
Post-void dribbling was recently determined to be one of
post-micturition symptoms that is distinct from TD. The
pathogenesis of post-micturition dribbling involves weak-
ness of the bulbocavernosus muscle, which results in fail-
ure to evacuate urine that has pooled and trapped in the
bulbar area of the urethra after voiding [17]. Additionally,
the ICS previously removed the term “terminal dribbling”
because of its similarity with post-void dribbling, which
could be the main reason why there have been few studies
on this issue [18]. To achieve the consistency, we con-
ducted face-to-face interview by a single investigator using
standardized definition of TD. Clinical studies on this
topic should describe the demographic characteristics of
the subjects, the prevalence of TD, the questionnaire used,
and the definition of TD. Table 4 summarizing the previ-
ous studies related with TD indicates that the prevalence
of TD is much greater in the LUTS patients than in the
community people.
Although few studies have been perform to investigate
TD, high rates have been observed in patients with LUTS
in both Western and Asian populations [2, 4, 19]. The
ICS–‘BPH’ study reported 91–96 % of symptom preva-
lence of TD in BPH patients and 73–79 % in community
people by ICS male questionnaire [4]. Korean study using
translated version of ICS male questionnaire also showed
that 86 % of male patients with LUTS had the symptom of
TD, which was the second most common symptom even
though TD has not been regarded as a bothersome symp-
tom [2]. In addition, the reported prevalence of TD in eld-
erly men was less than that of middle aged men [4]. This
may imply that TD is an early obstructive symptom and
that the patients with TD get used to this symptom as
time passes by. Interestingly, our results were consistent
with the previous study that the prevalence of TD in male
LUTS patients was higher in their 60’s compared with in
their 50’s and 70’s. TD does not seem to be the sign of the
early stages of LUTS because IPSS total score and IPSS
QoL score in TD group were significantly higher than
those in non-TD group.
Since there have been few studies investigating TD, its
associations with LUTS and several clinical parameters
have not been well characterized so far. In this study, TD
had an association with voiding subscore in IPSS but no
associations with serum PSA level, prostate volume, and
prostate transitional zone volume. Traditionally, TD has
been regarded as one of the voiding symptoms [4, 6, 13].
In addition, IPP has been reported to be associated with
voiding symptoms [9, 20, 21]. In the present study, IPSS
voiding subscore had a strong correlation with TD and
Table 2 The logistic regression analysis identifying the factors
affecting terminal dribbling
Variable Logistic Regression
OR 95 % Confidence interval p value
Age 1.00 0.98 – 1.02 0.707
PSA 0.98 0.94 – 1.02 0.262
Prostate volume (cm3) 1.00 0.99 – 1.01 0.626
Prostate transitional
zone volume (cm3)
0.98 0.96 – 1.00 0.089
IPP 1.41 0.96 – 2.09 0.083
IPSS total 1.00 0.93 – 1.07 0.901
Voiding subscore 1.06 1.02 – 1.09 0.001
Storage subscore 0.96 0.88 – 1.05 0.384
IPSS QoL 1.15 0.94 – 1.41 0.170
OR = odds ratio; PSA = prostate-specific antigen; IPP = intravesical prostatic
protrusion; IPSS = International Prostate Symptom Score; QoL = Quality of Life
*Backward variable selection procedure was applied
Table 3 The logistic regression analysis identifying the factors
affecting uroflowmetry-confirmed terminal dribbling
Variable Logistic Regression
OR 95 % Confidence interval p value
Age 0.99 0.97 – 1.01 0.530
PSA 0.97 0.92 – 1.02 0.273
Prostate volume (cm3) 1.00 0.99 – 1.01 0.752
Prostate transitional
zone volume (cm3)
1.00 0.99 – 1.02 0.713
IPP 2.83 1.91 – 4.21 <0.001
IPSS total 0.96 0.89 – 1.04 0.363
Voiding subscore 1.03 0.93 – 1.15 0.561
Storage subscore 1.01 0.96 – 1.07 0.600
IPSS QoL 1.23 0.98 – 1.55 0.070
OR = odds ratio; PSA = prostate-specific antigen; IPP = intravesical prostatic
protrusion; IPSS = International Prostate Symptom Score; QoL = Quality of Life
*Backward variable selection procedure was applied
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Table 4 Summary of previous studies on terminal dribbling
Source Study sample Prevalence Questionnaires used Definition of terminal dribbling Remark
Boyarsky et al. (1977) 4 Not a clinical study Not determined A pilot questionnaire with 10 items No specific definition of
terminal dribbling.
Suggested a guideline with a 10
item questionnaire including
terminal dribbling.
Garraway et al. (1991)20 Community sample 45 % A pilot questionnaire by Fowler16 Patients were asked to rate the







Meyhoff et al. (1993)12 LUTS patients Not determined DAN-PSS-1 “Do you experience dribbling
after voiding, when you












Terminal dribbling was noted
to be bothersome.
Reynard et al. (1996)6 LUTS patients 44 % in questionnaire, 27 %
in uroflowmetry
Not determined “Does your urinary stream
end with a dribble?” Gradient
of a line drawn between the
maximum flow rate and
the end of flow was <0.25
and if, in the terminal 15 s
of uninterrupted flow, the
flow rate did not exceed 5
ml/s at any point.
Pressure-flow study was
done. Terminal dribbling
on questionnaire was not
related to BOO defined by
pressure-flow study.
Hughes et al. (2000)1 Community sample 35 % ICS male questionnaire “Do you have any trickle/dribble
at the final part of micturition?”
Terminal dribbling was the
single- most bothersome
symptom.
Scarpa et al. (2001)2 LUTS patients 88 % ICS male questionnaire “Do you have any trickle/dribble
at the final part of micturition?”
Terminal dribbling was the both
most common and bothersome
symptom
Jin et al. (2003)3 LUTS patients 85.6 % ICS male questionnaire “Do you have any trickle/dribble
at the final part of micturition?”
Translated questionnaire in
Korean. Pressure-flow study
was done. IPP was not
checked.
Yano et al. (2004)16 LUTS patients Not determined Saitama Prostate Symptom Score “Do you experience dribbling after
voiding, when you feel you have
finished urination?”




Shiri et al. (2005)14 Community sample 52 % DAN-PSS-120 “Do you consider your urinary
stream as dribbling?”
Relationship between LUTS
and ED. Terminal dribbling
was related to ED.
LUTS = lower urinary tract symptoms; ICS = International Continence Society; BOO = bladder outlet obstruction; IPSS = International Prostate Symptom Score; IPP = intraprostatic protrusion; DAN-PSS-1 = Danish Prostate












IPP emerged as a significant risk factor for uroflowmetry-
confirmed TD.
Earlier reports have tended to put an emphasis on
objective tools such as uroflowmetry. However, 48 % of
the patients who reported TD did not show any objective
evidence of TD on uroflowmetry [6]. In our study, about
30 % of the patients did not show the typical finding of
TD on uroflowmetry. One of the reasons of this result is
probably that TD does not happen all the time in some
patients. Another reason to be considered is the large
amount of urine volume that the patients try to void when
they are taking the uroflowmetry test.
This study has several limitations. First, pressure flow
studies were not performed, and as a result we could not
confirm bladder outlet obstruction of each patient. How-
ever, the recent guideline recommends that pressure flow
studies should be considered before invasive treatment in
men with a Qmax greater than 10 ml per second and are
not necessarily needed in the patients whose maximum
flow rate is less than 10 ml per second [22]. Second, we
did not use the entire ICS male questionnaire because it
contains a large number of questions. Notably, however,
the initial developers of the questionnaire have recom-
mended the short form ICSmaleSF questionnaire omitting
duplicate or redundant items [19].
Conclusions
Among men with LUTS attending outpatient clinic, about
40 % of them complained of TD. IPSS voiding subscore
had a strong correlation with TD and IPP was the only
significant risk factor for uroflowmetry-confirmed TD. On
the other hand, the parameters such as age, PSA, prostate
volume and prostate transitional zone volume did not
show any significant association with it. TD is not corre-
lated with each question of IPSS, which means that TD is
the specific symptom among several LUTS. Further stud-
ies on TD will reveal the clinical impact of this underesti-
mated symptom on LUTS patients, and make it possible
to guide a proper management.
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